Finance

Lists
OKYO:NASDAQ
OKYO Pharma Ltd
1,44 US$
-0,35%
(-0,0050) 1D
12 ოქტ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OKYO...
Open
1,46 US$
High
1,49 US$
Low
1,40 US$
Mkt. cap
75,31 მლნ.
Avg. vol.
76,29 ათ.
Volume
70,37 ათ.
52-wk high
3,20 US$
52-wk low
1,26 US$
EPS
-0,32 US$
Beta
-0,03
Shares outstanding
52,48 მლნ.
No. of employees
5
Open
1,46 US$
High
1,49 US$
Low
1,40 US$
Mkt. cap
75,31 მლნ.
Avg. vol.
76,29 ათ.
Volume
70,37 ათ.
52-wk high
3,20 US$
52-wk low
1,26 US$
EPS
-0,32 US$
Beta
-0,03
Shares outstanding
52,48 მლნ.
No. of employees
5
News stories
From web sources and news partners
About OKYO Pharma Ltd
CEO-
Employees5
Founded2007
Headquarters-
Sector-
Analyst ratings
Based on 2 analysts giving stock ratings to OKYO in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for OKYO in the last 3 months.
Highest
Current 1,44 US$
7,00 US$ (+387,80%)
Average
6,00 US$ (+318,12%)
Lowest
5,00 US$ (+248,43%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yi Chen
H.C. Wainwright
Buy
Reiterated
5,00 US$
+248,4%
10/06/2026
Biren Amin
Piper Sandler
Buy
Maintained
7,00 US$
+387,8%
08/27/2026
William Wood
B. Riley Securities
Buy
Initiated
5,00 US$
+248,4%
12/08/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ივნ. 2025
სექ. 2025
დეკ. 2025
მარ. 2026
Revenue
-
-
-
-
Cost of goods sold
1,27 მლნ.
1,27 მლნ.
2,07 მლნ.
2,07 მლნ.
Cost of revenue
1,27 მლნ.
1,27 მლნ.
2,07 მლნ.
2,07 მლნ.
Research and development expenses
-22,02 ათ.
-22,02 ათ.
926,55 ათ.
926,55 ათ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
-22,02 ათ.
-22,02 ათ.
926,55 ათ.
926,55 ათ.
Total operating expenses
1,25 მლნ.
1,25 მლნ.
3,00 მლნ.
3,00 მლნ.
Operating income
-1,25 მლნ.
-1,25 მლნ.
-3,00 მლნ.
-3,00 მლნ.
Other non operating income
-
-
-140,00
-140,00
EBT including unusual items
-1,29 მლნ.
-1,29 მლნ.
-3,18 მლნ.
-3,18 მლნ.
EBT excluding unusual items
-1,29 მლნ.
-1,29 მლნ.
-3,18 მლნ.
-3,18 მლნ.
Income tax expense
26,00
26,00
3,97 ათ.
3,97 ათ.
Effective tax rate
-
-
-0,12%
-0,12%
Other operating expenses
-
-
-
-
Net income
-1,29 მლნ.
-1,29 მლნ.
-3,18 მლნ.
-3,18 მლნ.
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
16,05 ათ.
16,05 ათ.
Interest expense
-42,29 ათ.
-42,29 ათ.
-194,68 ათ.
-194,68 ათ.
Net interest expenses
-42,29 ათ.
-42,29 ათ.
-178,63 ათ.
-178,63 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,25 მლნ.
-1,25 მლნ.
-3,00 მლნ.
-3,00 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google აპები